Robuta

Sponsor of the Day: Jerkmate
https://www.biospace.com/fda/prasad-out-at-fda-lawmaker-takes-action-on-rare-disease-rejections-and-a-spate-of-obesity-data Prasad Out at FDA, Lawmaker Takes Action on Rare Disease Rejections, and a Spate of Obesity Data -... Mar 16, 2026 - Rare disease biotech stocks pop on the news that Vinay Prasad, the FDA’s chief biologics regulator, will depart the FDA at the end of April; Sen. Ron Johnson... takes actionrare diseaseobesity dataprasadfda https://www.genengnews.com/topics/translational-medicine/stockwatch-wave-plummets-50-on-obesity-data/ Wave Plummets 50% on Obesity Data Mar 30, 2026 - Disappointed investors punished Wave Life Sciences (NASDAQ: WVE), causing its shares to lose roughly half their value on Thursday after the RNA-based drug... obesity datawaveplummets50 https://www.biospace.com/drug-development/wave-stock-cut-in-half-on-underwhelming-higher-dose-obesity-data Wave Stock Cut in Half on Underwhelming Higher Dose Obesity Data - BioSpace Mar 26, 2026 - While participants on a lower dose of Wave Life Sciences’ RNA therapy lost 5.3% total fat at the six-month mark, those receiving the higher dose saw a less... obesity datawavestockcuthalf